News summary produced by Claude AI
A laboratory study from the University of Cambridge examined how commercial sweeteners affect the growth of beneficial gut bacteria. Researchers tested 25 different bacterial species commonly found in the human digestive system by exposing them to 39 commercially used sweeteners, including both natural and artificial varieties. Approximately three-quarters of the sweeteners tested altered the growth patterns of at least one bacterial species, with several reducing or completely halting the growth of bacteria associated with digestive health.
The investigation expanded to examine whether sweeteners’ effects changed when combined with other substances commonly consumed alongside them, such as caffeine, vanilla flavoring, and pharmaceutical drugs. Researchers identified over 100 instances where a sweetener’s impact on bacterial growth differed when paired with another compound. In 34 cases, combined effects became stronger, while in 68 cases they weakened, suggesting that the overall impact of a sweetener may depend partly on concurrent consumption of other substances.
The most pronounced effect occurred when isosteviol, a sweetener used in the food and beverage industry, was combined with duloxetine, an antidepressant medication widely prescribed for depression, anxiety, and chronic pain. This combination significantly suppressed two bacterial species considered important for digestive health and metabolic regulation. When researchers created a simplified microbial community containing all 25 bacterial species and exposed it to this combination, they observed reduced microbial diversity and changes in the community’s bacterial balance.
The study authors emphasized important limitations of their research. All experiments were conducted in controlled laboratory settings using isolated bacteria and cell models rather than in human subjects. They noted that in the actual human digestive system, sweeteners may be absorbed, altered chemically, diluted, or broken down before reaching specific microbes. Individual factors including diet, genetics, medication use, and existing microbiome composition could also influence outcomes. The researchers called for human studies to determine whether similar interactions occur in people and whether any observed microbial changes produce measurable health effects.